Flatiron Health expands AI-powered breast cancer, NSCLC real-world data to UK, Germany, Japan

• Roche unit Flatiron Health launched AI-extracted breast cancer and NSCLC real-world “Panoramic” datasets covering the UK, Germany, Japan.
• Expansion follows Flatiron’s multinational prostate cancer dataset launch in January 2026.
• New datasets use a common data model aligned with Flatiron’s US breast cancer and NSCLC datasets spanning nearly 1.5 million patients.
• Flatiron said the multinational offering roughly doubles patient coverage versus prior data offerings across the two tumor types and geographies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via Business Wire (Ref. ID: 202609290900BIZWIRE_USPR_____20260929_BW646093) on September 29, 2026, and is solely responsible for the information contained therein.